$GNVR·8-K

Genvor Inc · Apr 22, 11:48 AM ET

Compare

Genvor Inc 8-K

Research Summary

AI-generated summary

Updated

Genvor Inc Announces Financing Deal: Up to $800K Convertible Note

What Happened
Genvor Inc (GNVR) filed an 8-K reporting that on April 16, 2026 it entered a Securities Purchase Agreement (SPA) with Evergreen Capital Management LLC providing up to $800,000 in convertible promissory notes and warrants to purchase up to 600,000 shares, for a total purchase price of up to $666,668 paid in four tranches. The first tranche of $166,667 was funded and the Note and initial Warrants were issued on April 16, 2026. The company also entered an Advisory Agreement with Brio Advisory Group to assist with strategic initiatives and an Exchange Listing.

Key Details

  • Financing: up to $800,000 aggregate principal via a convertible note (four tranches of $200,000 principal each if fully funded); purchase price payable in four tranches of $166,667.
  • Timing and terms: first tranche funded April 16, 2026; Note accrues 10% annual interest and matures on the earlier of 9 months after the Issue Date (Issue Date noted as April 15, 2026) or a listing of the company’s common stock on a national exchange (e.g., Nasdaq).
  • Conversion & warrants: Note convertible at $1.00/share (or 80% of lowest 5‑day VWAP upon default); conversion capped so holder cannot exceed 4.99% beneficial ownership. Warrants initially cover 300,000 shares and will cover an additional 300,000 shares upon funding of the second tranche; 5‑year term, cashless exercise, $1.00 initial exercise price (adjustable to match Note conversion price).
  • Advisory fee: Brio Advisory Group to receive preferred shares valued at $300,000 per tranche (up to $1.2M total if all four tranches fund) at the time of an Exchange Listing, or convert to common stock after one year (not below $1.00 per share).

Why It Matters
This 8-K shows Genvor secured immediate, staged financing and advisory support intended to help the company pursue a public listing and other strategic initiatives. The financing provides near-term cash (first tranche funded) but carries potential dilution through note conversion and warrants and includes a meaningful advisory equity commitment (up to $1.2M value). Investors should note the conversion price and ownership cap, the relatively short maturity (nine months unless listed), and that additional funding tranches are contingent on the company filing a Form S-1 and receiving SEC comments.

Loading document...